At the Forefront: Social Workers’ Role in Psilocybin Treatment for Depression and Substance Misuse
Social Work – May 02, 2024
Source: OpenAlex
Summary
A compelling finding reveals that psilocybin, a potent hallucinogen, offers remarkable effectiveness for major depressive disorder and substance abuse, often after a single dose. This promising approach in medicine, particularly within psychiatry and psychology, is gaining traction. Clinical trials highlight psilocybin's long-lasting posttreatment effects, demonstrating its potential as a novel treatment. Social workers are crucial in integrating this psychedelic medicine into therapeutic practice, working alongside psychotherapists. This area of drug studies is rapidly evolving, recognized by the FDA as a "breakthrough therapy."
Abstract
Abstract This article underscores the critical role of social workers in harnessing the potential therapeutic benefits of psilocybin for treating major depressive disorder (MDD) and substance use disorder (SUD). Contemporary treatments for MDD often have side effects, and the success rate for SUD treatments remains low. The pervasiveness of MDD, combined with the challenges in treating SUD, highlights a need for innovative treatments. This article provides an overview of the resurgence of literature over the past two decades that illuminates the therapeutic promise of psilocybin for mental health treatment; clinical trials elucidate the efficacy of psilocybin-assisted therapy in mitigating MDD and demonstrate great promise in reducing SUD symptoms. The long-lasting posttreatment effect emphasizes its potential as a novel treatment modality. Furthermore, psilocybin’s recognition as a “breakthrough therapy” by the U.S. Food and Drug Administration (FDA) and the accelerating pace of psychedelic reform bills indicate growing acceptance and interest in its therapeutic capacities. Psilocybin-assisted therapy emerges as a potent treatment option, showcasing remarkable effectiveness even after a single dose. Recommendations and pathways for social workers to be involved in psilocybin-assisted therapy investigation, advocacy, and implementation are provided.